지속성 약물전달 기술 및 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 기술별, 제형별, 사용 재료별, 유통경로별, 지역별, 경쟁별 세분화(2020-2030년)

The Global Long-Acting Drug Delivery Technologies and Services Market, valued at USD 10.78 Billion in 2024, is projected to experience a CAGR of 11.10% to reach USD 20.27 Billion by 2030. Long-acting drug delivery technologies and services encompass systems designed to release therapeutic agents over extended periods, reducing dosing frequency and improving patient adherence. Primary drivers supporting market expansion include the increasing prevalence of chronic diseases necessitating sustained medication for optimal management and the growing demand for enhanced patient convenience, especially for injectable or implantable formulations. The inherent benefit of maintaining consistent drug levels, thereby minimizing peak-and-trough effects, also represents a fundamental driver for these innovative delivery solutions.

Key Market Drivers

The rising global burden of chronic diseases significantly influences the demand for long-acting drug delivery technologies and services, as these conditions necessitate sustained therapeutic management over extended periods. Diseases such as diabetes, cardiovascular disease, and various neurological disorders require consistent medication levels to prevent complications and improve patient outcomes.

Key Market Challenges

The significant financial investment associated with research and development (R&D) for novel long-acting formulations presents a notable impediment to the growth of the Global Long-Acting Drug Delivery Technologies and Services Market. This challenge directly results in substantial capital requirements and prolonged timelines before innovative products can achieve market entry. The complexity of developing formulations that ensure sustained release and stability over extended periods necessitates extensive preclinical and clinical testing, further escalating costs and extending development cycles.

Key Market Trends

The growing emphasis on biologic-based long-acting formulations represents a significant trend in the drug delivery market, driven by the increasing complexity of therapeutic molecules. These formulations extend the half-life of biologics, thereby reducing the frequency of injections which is crucial for patient comfort and adherence, especially for chronic conditions. Biologics, including monoclonal antibodies and protein-based therapies, often require complex manufacturing and administration regimens, making long-acting versions highly advantageous.

Key Market Players

• Adare Pharma Solutions
• Alkermes plc
• Camurus AB
• Corium, LLC.
• Creative Biolabs, Inc.
• Delpor, Inc.
• Durect Corporation
• Hanmi Pharm.Co.,Ltd.
• Integrated Bio Systems, Inc.
• Heron Therapeutics, Inc.

Report Scope:

In this report, the Global Long-Acting Drug Delivery Technologies and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Long-Acting Drug Delivery Technologies and Services Market, By Technique:

• Injectables
• Hydrogels
• Implants
• Microneedles
• NanocrystalSuspensions

Long-Acting Drug Delivery Technologies and Services Market, By Dosage Forms:

• Long-acting Injectables
• Long-acting Implantable
• Topical / Transdermal
• Vaginal
• Other

Long-Acting Drug Delivery Technologies and Services Market, By Material Used:

• Polymer based
• Non-polymer based

Long-Acting Drug Delivery Technologies and Services Market, By Distribution Channels:

• Hospitals and Retail Pharmacies
• Research and Academics
• Others

Long-Acting Drug Delivery Technologies and Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Long-Acting Drug Delivery Technologies and Services Market.

Available Customizations:

Global Long-Acting Drug Delivery Technologies and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Long-Acting Drug Delivery Technologies and Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Injectables, Hydrogels, Implants, Microneedles, NanocrystalSuspensions)
  • 5.2.2. By Dosage Forms (Long-acting Injectables, Long-acting Implantable, Topical / Transdermal, Vaginal, Other)
  • 5.2.3. By Material Used (Polymer based, Non-polymer based)
  • 5.2.4. By Distribution Channels (Hospitals and Retail Pharmacies, Research and Academics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Long-Acting Drug Delivery Technologies and Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique
  • 6.2.2. By Dosage Forms
  • 6.2.3. By Material Used
  • 6.2.4. By Distribution Channels
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Dosage Forms
      • 6.3.1.2.3. By Material Used
      • 6.3.1.2.4. By Distribution Channels
  • 6.3.2. Canada Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Dosage Forms
      • 6.3.2.2.3. By Material Used
      • 6.3.2.2.4. By Distribution Channels
  • 6.3.3. Mexico Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Dosage Forms
      • 6.3.3.2.3. By Material Used
      • 6.3.3.2.4. By Distribution Channels

7. Europe Long-Acting Drug Delivery Technologies and Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique
  • 7.2.2. By Dosage Forms
  • 7.2.3. By Material Used
  • 7.2.4. By Distribution Channels
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Dosage Forms
      • 7.3.1.2.3. By Material Used
      • 7.3.1.2.4. By Distribution Channels
  • 7.3.2. France Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Dosage Forms
      • 7.3.2.2.3. By Material Used
      • 7.3.2.2.4. By Distribution Channels
  • 7.3.3. United Kingdom Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Dosage Forms
      • 7.3.3.2.3. By Material Used
      • 7.3.3.2.4. By Distribution Channels
  • 7.3.4. Italy Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Dosage Forms
      • 7.3.4.2.3. By Material Used
      • 7.3.4.2.4. By Distribution Channels
  • 7.3.5. Spain Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Dosage Forms
      • 7.3.5.2.3. By Material Used
      • 7.3.5.2.4. By Distribution Channels

8. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique
  • 8.2.2. By Dosage Forms
  • 8.2.3. By Material Used
  • 8.2.4. By Distribution Channels
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Dosage Forms
      • 8.3.1.2.3. By Material Used
      • 8.3.1.2.4. By Distribution Channels
  • 8.3.2. India Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Dosage Forms
      • 8.3.2.2.3. By Material Used
      • 8.3.2.2.4. By Distribution Channels
  • 8.3.3. Japan Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Dosage Forms
      • 8.3.3.2.3. By Material Used
      • 8.3.3.2.4. By Distribution Channels
  • 8.3.4. South Korea Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Dosage Forms
      • 8.3.4.2.3. By Material Used
      • 8.3.4.2.4. By Distribution Channels
  • 8.3.5. Australia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Dosage Forms
      • 8.3.5.2.3. By Material Used
      • 8.3.5.2.4. By Distribution Channels

9. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique
  • 9.2.2. By Dosage Forms
  • 9.2.3. By Material Used
  • 9.2.4. By Distribution Channels
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Dosage Forms
      • 9.3.1.2.3. By Material Used
      • 9.3.1.2.4. By Distribution Channels
  • 9.3.2. UAE Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Dosage Forms
      • 9.3.2.2.3. By Material Used
      • 9.3.2.2.4. By Distribution Channels
  • 9.3.3. South Africa Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Dosage Forms
      • 9.3.3.2.3. By Material Used
      • 9.3.3.2.4. By Distribution Channels

10. South America Long-Acting Drug Delivery Technologies and Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique
  • 10.2.2. By Dosage Forms
  • 10.2.3. By Material Used
  • 10.2.4. By Distribution Channels
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Dosage Forms
      • 10.3.1.2.3. By Material Used
      • 10.3.1.2.4. By Distribution Channels
  • 10.3.2. Colombia Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Dosage Forms
      • 10.3.2.2.3. By Material Used
      • 10.3.2.2.4. By Distribution Channels
  • 10.3.3. Argentina Long-Acting Drug Delivery Technologies and Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Dosage Forms
      • 10.3.3.2.3. By Material Used
      • 10.3.3.2.4. By Distribution Channels

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Long-Acting Drug Delivery Technologies and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Adare Pharma Solutions
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Alkermes plc
• 15.3. Camurus AB
• 15.4. Corium, LLC.
• 15.5. Creative Biolabs, Inc.
• 15.6. Delpor, Inc.
• 15.7. Durect Corporation
• 15.8. Hanmi Pharm.Co.,Ltd.
• 15.9. Integrated Bio Systems, Inc.
• 15.10. Heron Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer